c2715364-848a-4dba-97c8-c043e9f7135e-PIN

Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease

Status
forthcoming
Estimated value
€1,200,000
Published
2 May 2025
Submission
Electronic submission
Tender summary

REASON FOR PURCHASING The Commission has to maintain a stock of at least 250.000 doses of live attenuated Lumpy Skin Disease (LSD) vaccine in storage in order to make it rapidly available in case it is needed. The listed estimated value is €1,200,000.

What the buyer needs

  • REASON FOR PURCHASING The Commission has to maintain a stock of at least 250.000 doses of live attenuated Lumpy Skin Disease (LSD) vaccine in storage in order to make it rapidly available in case it is needed. In…
  • The purchase of maximum 1.000.000 doses of live attenuated homologous vaccine against LSD. This will be executed with one initial purchase of 250.000 and up to three (3) replenishments, of maximum 250.000 doses each…
  • The storage of a stock of 250.000 doses, readily available for delivery to any of the destinations listed in the technical specifications, that can be replaced, if depleted, partially or totally, up to 5 times until the…
  • The timely delivery of maximum 2.000.000 doses divided in as many consignments as needed to any of the destinations listed in the technical specifications

Procurement signals

  • Procedure: EC-SANTE/2025/OP/0021-PIN
  • Procedure type: Source procedure code 47396222
  • Contract type: Supply contract (31095499)
  • Submission method: Electronic submission
  • Published: 2 May 2025

Procurement categories

CPV 33651690

CPV labels are not yet mapped locally, so the official category codes are shown as source-backed identifiers.

Programme and geography

Programme period 2014 - 2020Programme period 2021 - 2027

Derived from official EU Funding & Tenders portal source fields. Use this as a shortlisting aid; the official tender record remains authoritative.

Source-backed details

Original identifiers and classification fields from the EU tender source.

Procedure identifier
EC-SANTE/2025/OP/0021-PIN
Business identifier
c2715364-848a-4dba-97c8-c043e9f7135e-PIN
Procedure type
Source procedure code 47396222
Contract type
Supply contract (31095499)
Authority source ID
47352504
Tender timezone
Europe/Brussels
Fetched
17 Jun 2026, 21:04 UTC
Full official description

REASON FOR PURCHASING The Commission has to maintain a stock of at least 250.000 doses of live attenuated Lumpy Skin Disease (LSD) vaccine in storage in order to make it rapidly available in case it is needed. In addition, this stock of 250.000 doses of live attenuated vaccine should be replaced quickly, within 4 weeks, when depleted, in order to maintain the Union’s capability to respond to an emergency. PROCUREMENT DESCRIPTION The purpose of the contract is: • The purchase of maximum 1.000.000 doses of live attenuated homologous vaccine against LSD. This will be executed with one initial purchase of 250.000 and up to three (3) replenishments, of maximum 250.000 doses each, upon request from the Commission. • The storage of a stock of 250.000 doses, readily available for delivery to any of the destinations listed in the technical specifications, that can be replaced, if depleted, partially or totally, up to 5 times until the end of the contract, upon request from the Commission. • The timely delivery of maximum 2.000.000 doses divided in as many consignments as needed to any of the destinations listed in the technical specifications • The storage of any vaccines in stock at the end of the contract for the remainder of their shelf life • The proper destruction and disposal of any unused vaccine at the end of its self life.